Acorda therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Acorda therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 47.722 million compared to usd 142.814 million a year ago. operating loss was usd 259.350 million compared to operating income of usd 28.297 million a year ago. net loss was usd 263.535 million compared to usd 13.911 million a year ago. basic loss per share was usd 5.55 compared to usd 0.29 a year ago. for the nine months, total revenue was usd 141.911 million compared to usd 402.281 million a year ago. operating loss was usd 326.118 million compared to operating income of usd 87.787 million a year ago. net loss was usd 338.626 million compared to net income of usd 24.087 million a year ago. basic loss per share was usd 7.13 compared to basic earnings per share of usd 0.51 a year ago.
ACOR Ratings Summary
ACOR Quant Ranking